Position in WVE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$28,599,590
-$9,047,926 QoQ
Shares Held
4,922,477
-5.2% QoQ
Ownership
2.50%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 237 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WVE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. WVE ranks #131 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in WVE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,599,590 | 4,922,477 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $37,647,516 | 5,192,761 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $257,311,711 | 15,135,983 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $37,554,337 | 5,130,374 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,024,390 | 619,137 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $17,330,202 | 2,144,827 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $22,608,896 | 1,827,720 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $12,629,558 | 1,540,190 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,799,789 | 561,080 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,211,329 | 1,168,773 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,071,185 | 1,202,215 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,797,443 | 660,425 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,818,408 | 774,288 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,483,870 | 1,035,536 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $12,330,052 | 1,761,436 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,608,926 | 2,107,736 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $4,023,584 | 1,238,026 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $133,188 | 66,594 | Shares | Defined | 2022-05-13 | |
| 2020-12-31 | $1,766,815 | 224,500 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $2,390,784 | 281,600 | Shares | Defined | 2020-11-13 | |
| 2020-03-31 | $621,633 | 66,343 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||